Safety Related Changes
CellCept (mycophenolate mofetil) is now also contraindicated during pregnancy due to its mutagenic and teratogenic potential; in women of childbearing potential not using highly effective contraceptive methods; and in women who are breastfeeding.
Patients should be advised that alcohol intake may increase the risk of experiencing neuropsychiatric events during treatment with Champix (varenicline (as tartrate)).
Copyright © MIMS Australia Pty Ltd. All rights reserved.
Level 2, 1 Chandos Street
St Leonards NSW 2065
Phone: 1800 800 629